MFLens
Trailing returns lie. Rolling data doesn’t.Nippon India Pharma Fund
Sector/ThematicNippon India Mutual Fund
GOOD QUALITY60/100
Ranks #32 of 107 Sector/Thematic funds
Track Record
81.3%
3Y rolling
Sharpe Ratio
0.60
3Y
Alpha
6.70%
vs benchmark · 3Y
CAGR
17.03%
3Y annualised
Full analysis at mflens.in
1 August 2026
Past performance does not guarantee future returns. Data via MFLens rolling analysis.